Literature DB >> 17040360

Bronchiectasis.

P King1, S Holdsworth, N Freezer, P Holmes.   

Abstract

Bronchiectasis is generally classified into cystic fibrosis and non-cystic fibrosis bronchiectasis. This review article describes non-cystic fibrosis bronchiectasis in adults. Bronchiectasis can be considered a heterogeneous condition characterized by irreversible airway dilatation with chronic bronchial infection/inflammation. It remains a common condition and is a major cause of respiratory morbidity. Many factors are associated with bronchiectasis, but most commonly patients will have idiopathic disease. Important clinical findings include chronic productive cough, rhinosinusitis, fatigue and bi-basal crackles. Patients have usually had symptoms for many years. Diagnosis is confirmed by high-resolution computed tomography scanning using standardized criteria. Spirometry shows moderate airflow obstruction and there is a high prevalence of bronchial hyperreactivity. The most common pathogens are non-typeable Haemophilus influenzae and Pseudomonas aeruginosa. There may be considerable overlap with other chronic airway diseases. Treatment regimens are still not well defined. Patients tend to have ongoing symptoms and decline in respiratory function despite treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17040360     DOI: 10.1111/j.1445-5994.2006.01219.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  27 in total

1.  CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters.

Authors:  L J Maarschalk-Ellerbroek; P A de Jong; J M van Montfrans; J W J Lammers; A C Bloem; A I M Hoepelman; P M Ellerbroek
Journal:  J Clin Immunol       Date:  2014-06-21       Impact factor: 8.317

Review 2.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

3.  Computed Tomography Findings of Bronchiectasis in Different Respiratory Phases Correlate with Pulmonary Function Test Data in Adults.

Authors:  Ricardo Holderbaum do Amaral; Carlos S Nin; Vinicius V S de Souza; Giordano R T Alves; Edson Marchiori; Klaus Irion; Gustavo S P Meirelles; Bruno Hochhegger
Journal:  Lung       Date:  2017-03-28       Impact factor: 2.584

Review 4.  Arsenic Exposure and Immunotoxicity: a Review Including the Possible Influence of Age and Sex.

Authors:  Daniele Ferrario; Laura Gribaldo; Thomas Hartung
Journal:  Curr Environ Health Rep       Date:  2016-03

5.  Survival in Patients with Advanced Non-cystic Fibrosis Bronchiectasis Versus Cystic Fibrosis on the Waitlist for Lung Transplantation.

Authors:  Don Hayes; Benjamin T Kopp; Joseph D Tobias; Frederick W Woodley; Heidi M Mansour; Dmitry Tumin; Stephen E Kirkby
Journal:  Lung       Date:  2015-10-01       Impact factor: 2.584

6.  Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases.

Authors:  Guillaume Geri; Sabrina Dadoun; Tach Bui; Nuria Del Castillo Pinol; Simon Paternotte; Maxime Dougados; Laure Gossec
Journal:  BMC Infect Dis       Date:  2011-11-02       Impact factor: 3.090

Review 7.  Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?

Authors:  Paul King
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  Airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2015-11-23

9.  In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.

Authors:  Carolyn L Cannon; Lisa A Hogue; Ravy K Vajravelu; George H Capps; Aida Ibricevic; Khadijah M Hindi; Aysegul Kascatan-Nebioglu; Michael J Walter; Steven L Brody; Wiley J Youngs
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

10.  Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis.

Authors:  Andrea Cristina Pereira; Cristina M Kokron; Beatriz Mangueira Saraiva Romagnolo; Claudia Simeire Albertini Yagi; Paulo Hilário Nascimento Saldiva; Geraldo Lorenzi Filho; Elnara Marcia Negri
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.